Asthma and COPD Drugs (Izard) Flashcards

1
Q

What are the two goals of asthma therapy?

A

Reduction in impairment

Reduction in risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most widely used drug class in asthma/COPD treatment?

A

Beta-2 receptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary action of Beta-2 agonists

A

Relax airway smooth-muscle cells of all airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Albuterol class?

A

Short acting beta agonist (SABA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Albuterol contraindications/warnings?

A

Paradoxical bronchospasm

CV effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Terbutaline class?

A

SABA with preferential effects on the beta-2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Terbutaline uniqueness?

A

Only beta-2 drug available by subQ injection.

Can’t give in patients with sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Age approved in use of terbutaline?

A

12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metaproterenol class?

A

SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metaproterenol indication?

A

bronchial asthma and reversible bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metaproterenol warnings?

A

paradoxical bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pirbuterol class?

A

SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pirbuterol indication? Age?

A

prevention and reversal of bronchospasm in patients 12 and older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pirbuterol cautions?

A

can produce a clinically significant CV effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Levalbuterol class?

A

SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Levalbuterol indication?

A

treatment or prevention of bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Levalbuterol age?

A

4 years or older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Levalbuterol caution/warning?

A

Paradoxical bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Beclomethasone class?

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Beclomethasone indication? Age?

A

maintenance/treatment of asthma and as prophylactic therapy in patients 5 and older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Beclomethasone cautions/warnings?

A

Deaths due to adrenal insufficiency have occured in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids .

Several months are required for recovery of HPA function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Most effective class for controlling asthma?

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which cells to ICS remove in the airway?

A

Eosinophils, Mast cells, and T lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Major effect of corticosteroids in asthma?

A

switch off the transcription of multiple activated genes that encode inflammatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

ICS dosing?

A

twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

If ICS does not control asthma, what is the next step?

A

LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Budesonide class?

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Budesonide indication? Age?

A

Maintenance treatment of asthma as prophylactic therapy in patients 6 years and older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Budesonide caution/warning?

A

Should not be used where primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Ciclesonide class?

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Ciclesonide indication? Age?

A

Maintenance treatment of asthma as prophylactic therapy in patients 12 years and older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ciclesonide cautions/warnings?

A

Not indicated for Asthma attacks

Use not recommended when patient has presence of Candida albicans infection of mouth/pharynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Flunisolide class?

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Flunisolide indication? Age

A

Maintenance treatment of asthma as prophylactic therapy in patients 6 years and older.

Asthma patients requiring oral corticosteroid therapy, where adding flunisolide therapy may reduce or eliminate the need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Fluticasone class?

A

ICS

36
Q

Fluticasone indication? Age?

A

Maintenance treatment of asthma as prophylactic therapy in patients 4 and older.

37
Q

Fluticasone cautions

A

Candida albicans infection of the mouth and pharynx may occur.

38
Q

Mometasone class?

A

ICS

39
Q

Mometasone indication? Age?

A

Asthma as prophylactic therapy in patients 4 and older.

40
Q

Mometasone cautions?

A

hypersensitivity to milk proteins

41
Q

Triamcinolone class?

A

ICS

42
Q

Triamcinolone indications?

A

Asthma

Patients who require systemic corticosteroid administration, where adding this agent may reduce or eliminate the need for the systemic corticosteroids

43
Q

Triamcinolone cautions?

A

Status asthmaticus or other acute episodes of asthma where intensive measures are required.

Care is needed in patients who are transferred from systemically active corticosteroids to Triamcinolone because deaths due to adrenal insufficiency have occurred.

44
Q

Oral and parenteral corticosteroid uses?

A

used in combination with SABAs to treat moderate to sever asthma flare-ups.

More likely to cause side effects

45
Q

Prednisone class?

A

OCS

46
Q

Prednisone indication?

A

Anti-inflammatory or immunosuppressive agent

treatment of certain endocrine conditions

47
Q

Prednisone cautions?

A

Adrenal Insufficiency

May lead to HPA axis suppression

48
Q

Fomoterol class?

A

LABA

49
Q

Fomoterol indication? Age?

A

Add on to an inhaled corticosteroid in asthma patients >5 yeras old.

COPD maintenance

50
Q

Fomoterol Contraindications?

A

LABAs increase risk of asthma-related deaths and asthma related hospitalizations, must use with use of a long-term asthma control medication.

51
Q

Salmeterol class?

A

LABA

52
Q

Salmeterol indication? Age?

A

exercise-induced bronchospasm in patients aged 4 and older.

COPD maintenance

53
Q

Indaceterol and Vilanterol class?

A

LABAs

54
Q

Indaceterol and Vilanterol indication?

A

breathing problems caused by COPD

55
Q

Olodaterol class?

A

LABA

56
Q

Olodaterol indication?

A

chronic bronchitis
emphysema

Used in the long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients

57
Q

MOA for anticholinergic drugs?

A

block acetylcholine from binding to its receptors on certain nerve cells.

Inhibit parasympathetic nerve impulses

anti-muscarinic agents most widely used in asthma/COPD

58
Q

Atropine class?

A

anticholinergic

59
Q

Atropine indication?

A

temporary blockade of severe or life threatening muscarinic effects.

60
Q

Atropine cautions?

A

atropine-induced tachycardia
Increased myocardial oxygen demand.

total dose should be restricted to 2 to 3 mg to avoid detrimental effects

61
Q

Ipratropium class?

A

anticholinergic

62
Q

Ipratropium indicaiton?

A

maintenance treatment of bronchospasm

poorly absorbed after aerosol administration and is therefore relatively free of systemic atropine-like effects

63
Q

Tiotropium class?

A

anticholinergic

64
Q

Tiotropium indication?

A

long-term, once-daily, maintenance treatment of bronchospasm

65
Q

Aclidinium class?

A

Anticholinergic

66
Q

Aclidinium indication?

A

long-term maintenance treatment of bronchospasm associated with COPD

67
Q

Theophyline class?

A

Methylxanthine

68
Q

Theophylline MOA?

A

Smooth muscle relaxation

suppression of the response of the airways to stimuli

69
Q

Theophylline cautions?

A

use extreme caution in patients with:

active peptic ulcer disease

seizure disorders

cardiac arrhythmias

70
Q

Leukotriene antagonist MOA?

A

Block cysteinyl leukotriene receptors and blocking their subsequent inflammatory cascade

71
Q

Montelukast class

A

Leukotriene antagonist

72
Q

Montelukast MOA

A

inhibit LTD4 at the CysLT1 receptor without any agonist activity

73
Q

Montelukast indications

A

allergies and prevent asthma attacks

74
Q

Montelukast cautions

A

Can’t use in acute asthma attacks

75
Q

Zafirlukast class?

A

Leukotriene antagonist

76
Q

Zafirlukast MOA?

A

selective and competitive receptor antagonist of Leukotriene D4 and E4

77
Q

Zafirlukast indication? Age?

A

Prophylaxis and chronic treatment of asthma in patients 5 years and older

78
Q

Zafirlukast caution?

A

Hepatotoxicity

79
Q

Zileuton MOA?

A

inhibitor of 5-lipoxygenase and thus inhibits LTB4, C4, D4, and E4 formation

80
Q

Is zileuton IR or ER?

A

ER

81
Q

Zileuton indication? Age?

A

Prophylaxis and chronic treatment of asthma in patients 12 years and older

82
Q

Zileuton caution

A

Active liver disease/ liver enzymes 3x upper limit

83
Q

Omalizumab class

A

Monoclonal antibody

84
Q

Omalizumab MOA/indication?

A

anti-IgE antibody indicated for moderate to severe persistent asthma in patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen.

Chronic idiopathic urticaria in patients 12 years and older if h1 antihistamine treatment isn’t working.

85
Q

Omalizumab caution

A

Anaphylaxis